HEADACHE Act
Key claim: The HEADACHE Act (HR5536, 119th Congress) was introduced and referred to the House Committee on Energy and Commerce on 2025-09-19.
Abstract
(HR5536 · 119th Congress) Latest action (2025-09-19): Referred to the House Committee on Energy and Commerce.
Why this matters
HR5536 (HEADACHE Act) has been introduced and referred to House Energy and Commerce, but no legislative text or findings are yet available beyond the short title, so the practical implication for patients, providers, or insurers cannot be determined. Tracking the referral establishes a placeholder in the 119th Congress health legislative pipeline until committee text clarifies whether it addresses coverage, research, workforce training, or FDA-regulated therapies for headache disorders.